These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19301987)

  • 1. Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma.
    Barker LC; Brand IR; Crawford SM
    Curr Med Res Opin; 2009 May; 25(5):1105-9. PubMed ID: 19301987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice.
    Lara AC; Cândido EB; Vidigal PV; Rocha AL; Carvalho-Macedo AC; Carneiro MM; Silva-Filho AL
    Acta Cir Bras; 2016 Apr; 31(4):286-93. PubMed ID: 27168542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women.
    Agorastos T; Vaitsi V; Pantazis K; Efstathiadis E; Vavilis D; Bontis JN
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):239-40. PubMed ID: 15653211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letrozole as primary therapy for endometrial hyperplasia in young women.
    Li HZ; Chen XN; Qiao J
    Int J Gynaecol Obstet; 2008 Jan; 100(1):10-2. PubMed ID: 17889878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma].
    Bershteĭn LM; Danilova MA; Kovalevskiĭ AIu; Gershfel'd ED; Poroshina TE; Tsyrlina TE; Meshkova IE; Turkevich EA; Maksimov SIa
    Vopr Onkol; 2009; 55(3):314-8. PubMed ID: 19670731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
    Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
    Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
    Stilwill SE; Cooper BC
    J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.
    Liang YJ; Hao Q; Wu YZ; Wang QL; Wang JD; Hu YL
    Int J Gynecol Cancer; 2009 Oct; 19(7):1248-52. PubMed ID: 19823063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
    Bellone S; Shah HR; McKenney JK; Stone PJ; Santin AD
    Am J Obstet Gynecol; 2008 Sep; 199(3):e7-e10. PubMed ID: 18550023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of aromatase inhibitors in the adjuvant setting.
    Goss PE
    Am J Clin Oncol; 2003 Aug; 26(4):S27-33. PubMed ID: 12902874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study.
    Thangavelu A; Hewitt MJ; Quinton ND; Duffy SR
    Gynecol Oncol; 2013 Dec; 131(3):613-8. PubMed ID: 24076063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
    Bilotas M; Meresman G; Stella I; Sueldo C; Barañao RI
    Fertil Steril; 2010 May; 93(8):2513-8. PubMed ID: 19819437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
    Rose C
    Am J Clin Oncol; 2003 Aug; 26(4):S9-16. PubMed ID: 12902872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibition in male breast cancer patients: biological and clinical implications.
    Doyen J; Italiano A; Largillier R; Ferrero JM; Fontana X; Thyss A
    Ann Oncol; 2010 Jun; 21(6):1243-1245. PubMed ID: 19861576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
    Buzdar AU; Robertson JF; Eiermann W; Nabholtz JM
    Cancer; 2002 Nov; 95(9):2006-16. PubMed ID: 12404296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma.
    Yamaguchi M; Erdenebaatar C; Saito F; Motohara T; Miyahara Y; Tashiro H; Katabuchi H
    Int J Gynecol Cancer; 2015 Nov; 25(9):1645-51. PubMed ID: 26495759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma.
    Bogliolo S; Gardella B; Dominoni M; Musacchi V; Cassani C; Zanellini F; De Silvestri A; Gaggero CR; Babilonti L; Spinillo A
    Arch Gynecol Obstet; 2016 Apr; 293(4):701-8. PubMed ID: 26671487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C; Keam SJ
    Pharmacoeconomics; 2006; 24(5):495-517. PubMed ID: 16706574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer.
    Glück S; Gorouhi F
    Am J Health Syst Pharm; 2011 Sep; 68(18):1699-706. PubMed ID: 21880884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.